Long-Term Treatment Effect With Tildrakizumab in Participants With Plaque Psoriasis

NCT04339595 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

47

Enrollment

INDUSTRY

Sponsor class

Stopped Low Recruitment

Conditions

Plaque Psoriasis

Interventions

BIOLOGICAL: Tildrakizumab

Sponsor

Almirall, S.A.